VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FTHFaeth Therapeutics, Inc.
$9.04$568M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFTHInstitutional Holders

FTH logoFaeth Therapeutics, Inc. (FTH) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+46.11 pp), though top 10 holders maintain a highly concentrated 74.3% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
54.5%$334M total value · ▲ +46.11 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
56 / 100
Neutral
Institutions & Flow45 holders+16 net flow (+22 / -6)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+16)
  • Top 10 holders control 74.3% of institutional value
  • Insiders Buying

Top Institutional Holders of FTH

Ranked by reported Q2 2026 13F market value

Top 10 Holders
74.3%
Top 25 Holders
98.8%

Share of total reported institutional value in FTH held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1MONTANOVA CAPITAL, LLC2.0M$50.5M+5747.1%7.818%0.92%
2Avoro Capital Advisors LLC1.4M$36.1M—5.588%0.32%
3BAKER BROS. ADVISORS LP1.3M$32.2M—4.978%0.16%
4BALYASNY ASSET MANAGEMENT L.P.1.0M$26.1M+6331.3%4.033%0.03%
5RA CAPITAL MANAGEMENT, L.P.722K$18.1M—2.794%0.16%
6Vivo Capital, LLC722K$18.1M0.0%2.794%1.65%
7Logos Global Management LP722K$18.1M+2306.7%2.794%0.78%
8Fairmount Funds Management LLC722K$18.1M—2.794%1.19%
9Caligan Partners LP629K$15.7M+399.6%2.436%0.74%
10B Group, Inc.610K$15.3M—2.361%7.16%
11Trails Edge Capital Partners, LP515K$12.9M+312.3%1.994%2.05%
12FRANKLIN TEMPLETON INC495K$12.4M+270.4%1.914%0.00%
13Octagon Capital Advisors LP361K$9.0M—1.397%0.81%
14ADAR1 Capital Management, LLC361K$9.0M—1.397%0.41%
15Cormorant Asset Management, LP1.0M$7.7M+235.8%3.979%0.39%
16MARSHALL WACE, LLP207K$5.2M+214.2%0.799%0.00%
17Boxer Capital Management, LLC181K$4.5M—0.699%0.34%
18Patient Square Capital LP175K$4.4M—0.677%0.68%
19Alyeska Investment Group, L.P.144K$3.6M—0.559%0.01%
20Affinity Asset Advisors, LLC144K$3.6M—0.559%0.16%
21BOOTHBAY FUND MANAGEMENT, LLC134K$3.3M+411.6%0.517%0.04%
22AWM Investment Company, Inc.111K$2.8M—0.431%0.24%
23Richmond Investment Services, LLC80K$2.0M—0.308%0.63%
24Ikarian Capital, LLC35K$885K+457.2%0.137%0.10%
25UBS Group AG22K$539K+375.6%0.083%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in FTH — a direct measure of their conviction.

Quarterly Institutional Activity

Filings activity in FTH during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers22Added To16Trimmed7Exited6

New Buyers

22

Institutions that opened a new FTH position in Q2 2026

  • Avoro Capital Advisors LLC$36.1M
  • BAKER BROS. ADVISORS LP$32.2M
  • RA CAPITAL MANAGEMENT, L.P.$18.1M
  • Fairmount Funds Management LLC$18.1M
  • B Group, Inc.$15.3M
  • Octagon Capital Advisors LP$9.0M
  • ADAR1 Capital Management, LLC$9.0M
  • Boxer Capital Management, LLC$4.5M
  • Patient Square Capital LP$4.4M
  • Alyeska Investment Group, L.P.$3.6M
  • Affinity Asset Advisors, LLC$3.6M
  • AWM Investment Company, Inc.$2.8M

Exited Positions

6

Institutions that fully closed their FTH position in Q2 2026

  • MILLENNIUM MANAGEMENT LLC$4.6M
  • STEMPOINT CAPITAL LP$4.2M
  • GOLDMAN SACHS GROUP INC$1.9M
  • BANK OF AMERICA CORP /DE/$1.0M
  • Brevan Howard Capital Management LP$641K
  • FRED ALGER MANAGEMENT, LLC$578K

FTH Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 202645+50%54.46%+46.11 pp$334M+405%
Q1 202630+200%8.35%+4.53 pp$66M+12749%
Q4 202510+11%3.82%0.09 pp$1M+10%
Q3 2025925%3.91%2.94 pp$0M23%
Q2 20251243%6.85%0.34 pp$1M20%
Q1 20252113%7.19%1.52 pp$1M34%
Q4 202424+20%8.71%+0.49 pp$1M13%
Q3 202420—8.22%—$1M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

Recent Insider Activity in FTH

Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as a key fundamental indicator because executives are risking personal capital.

DateInsiderActionSharesPriceValue
Jun 24, 2026STEPHENSON BRIAN C Buy3K$25.22$73K
Jun 22, 2026STEPHENSON BRIAN C Buy2K$20.23$36K

How FTH Compares to Peers

Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
DMRADamora Therapeutics, Inc.$1.46B200.0%99+33
LONALeonaBio, Inc.$17M184.4%45+4
KYNBKyntra Bio, Inc.$15M26.9%29-4
CNSYCerenome, Inc.$5M4.8%24-5
NXTSNexentis Technologies Inc.$291013.3%9-1

FTH — Frequently Asked Questions

Quick answers to the most common questions about buying FTH stock.

What percentage of FTH is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Faeth Therapeutics, Inc. stands at 54.5%, held across 45 reporting institutions.

Who is the largest institutional holder of FTH?

MONTANOVA CAPITAL, LLC is the largest reported institutional holder of FTH, with approximately 2,020,103 shares worth $0.05B as of Q2 2026.

Is FTH a hedge fund favorite?

No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of FTH.

What is FTH's Smart Money Score?

Our composite Smart Money Score for FTH is 56 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought FTH this quarter?

22 institutions opened new positions in FTH during Q2 2026, while 6 fully exited. 16 added to existing positions and 7 trimmed.

How is institutional ownership of FTH changing?

FTH institutional ownership rose by 46.11 percentage points quarter-over-quarter, with a net change of +15 holders.

How concentrated is FTH ownership among the top holders?

The top 10 institutions account for 74.3% of all reported 13F value in FTH, and the top 25 account for 98.8%.

How does FTH compare to Oncology Biotech on institutional ownership?

Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%), NXTS (3.3%). See the peer comparison table on this page for net buyer activity by company.

Where does this FTH institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.